Flavonoid apigenin is an inhibitor of the NAD+ase CD38

Implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome (Diabetes (2013) 62 (1084-1093))

Carlos Escande, Veronica Nin, Nathan L. Price, Verena Capellini, Ana P. Gomes, Maria Thereza Barbosa, Luke O'Neil, Thomas A. White, David A. Sinclair, Eduardo Nunes Chini

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1428
Number of pages1
JournalDiabetes
Volume63
Issue number4
DOIs
StatePublished - Apr 2014

Fingerprint

Apigenin
Acetylation
Flavonoids
NAD
Proteins
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Flavonoid apigenin is an inhibitor of the NAD+ase CD38 : Implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome (Diabetes (2013) 62 (1084-1093)). / Escande, Carlos; Nin, Veronica; Price, Nathan L.; Capellini, Verena; Gomes, Ana P.; Barbosa, Maria Thereza; O'Neil, Luke; White, Thomas A.; Sinclair, David A.; Chini, Eduardo Nunes.

In: Diabetes, Vol. 63, No. 4, 04.2014, p. 1428.

Research output: Contribution to journalArticle

Escande, Carlos ; Nin, Veronica ; Price, Nathan L. ; Capellini, Verena ; Gomes, Ana P. ; Barbosa, Maria Thereza ; O'Neil, Luke ; White, Thomas A. ; Sinclair, David A. ; Chini, Eduardo Nunes. / Flavonoid apigenin is an inhibitor of the NAD+ase CD38 : Implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome (Diabetes (2013) 62 (1084-1093)). In: Diabetes. 2014 ; Vol. 63, No. 4. pp. 1428.
@article{cd383a8fcb614b298fe7b851eab70a03,
title = "Flavonoid apigenin is an inhibitor of the NAD+ase CD38: Implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome (Diabetes (2013) 62 (1084-1093))",
author = "Carlos Escande and Veronica Nin and Price, {Nathan L.} and Verena Capellini and Gomes, {Ana P.} and Barbosa, {Maria Thereza} and Luke O'Neil and White, {Thomas A.} and Sinclair, {David A.} and Chini, {Eduardo Nunes}",
year = "2014",
month = "4",
doi = "10.2337/db14-er04",
language = "English (US)",
volume = "63",
pages = "1428",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Flavonoid apigenin is an inhibitor of the NAD+ase CD38

T2 - Implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome (Diabetes (2013) 62 (1084-1093))

AU - Escande, Carlos

AU - Nin, Veronica

AU - Price, Nathan L.

AU - Capellini, Verena

AU - Gomes, Ana P.

AU - Barbosa, Maria Thereza

AU - O'Neil, Luke

AU - White, Thomas A.

AU - Sinclair, David A.

AU - Chini, Eduardo Nunes

PY - 2014/4

Y1 - 2014/4

UR - http://www.scopus.com/inward/record.url?scp=84897823605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897823605&partnerID=8YFLogxK

U2 - 10.2337/db14-er04

DO - 10.2337/db14-er04

M3 - Article

VL - 63

SP - 1428

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 4

ER -